U.S. Healthcare Services Stock News

Custom Truck One Source (CTOS) has wrapped up FY 2025 with fourth quarter revenue of US$528.2 million and basic EPS of US$0.09, alongside trailing twelve month revenue of about US$1.94 billion and a trailing EPS loss of US$0.14. The company has seen quarterly revenue move from US$447.2 million in Q3 2024 to US$482.1 million in Q3 2025 and then to US$528.2 million in Q4 2025. EPS shifted from a loss of US$0.07 in Q3 2024 and US$0.13 in Q2 2025 to a profit of US$0.09 in Q4 2025. This puts the...

Why Luckin Coffee is on investor watchlists Luckin Coffee (OTCPK:LKNC.Y) has been drawing attention as investors reassess the stock after a period where the share price and business metrics offer a mixed picture of risk and opportunity. The shares recently closed at US$35.52, with returns over the past year, past 3 months and month pointing in different directions. This can prompt investors to look more closely at what they are paying for the company’s current earnings and growth profile. See...

Citigroup (NYSE:C) has issued its first digitally native structured note on Euroclear's distributed ledger technology platform. The deal marks the debut of a digitally native structured note on Euroclear's Digital Financial Market Infrastructure within wealth management. This transaction is positioned as a step toward digitizing financial market infrastructure and post trade processes. For investors tracking Citigroup, the launch of a digitally native structured note comes as the stock...

If you are wondering whether monday.com is starting to look interesting at current levels, this article will walk through how its price compares with a few different ways of thinking about value. The stock recently closed at US$77.60, with a 5.5% gain over the last 7 days, set against a 20.8% decline over the past month and a 45.9% decline year to date. That naturally raises questions about how the market is reassessing its potential and risk. Recent coverage has focused on monday.com as a...

Procter & Gamble (PG) is back in focus after a stronger than expected quarter, lower projected tariff costs, fresh renewable energy progress, and a series of supportive moves from large institutional investors and research firms. See our latest analysis for Procter & Gamble. At a share price of $156.01, Procter & Gamble has given investors an 11.58% 90 day share price return and a 10.03% year to date share price return. The 1 year total shareholder return of a 7.41% decline contrasts with the...

KVH Industries (KVHI) closed out FY 2025 with Q4 revenue of US$30.5 million and basic EPS of roughly US$0.02, alongside net income of about US$0.3 million. Over the past year, the company has seen quarterly revenue range from US$25.4 million to US$30.5 million, while basic EPS has swung between a loss of around US$0.36 in Q3 2025 and a profit of about US$0.05 in Q2 2025. This gives investors a clear view of how volatile margins have been. With trailing 12 month figures still pointing to an...

If you are wondering whether Cisco Systems' current share price lines up with its underlying worth, this article walks through what the numbers are saying about value. Over shorter periods the stock has been choppy, with a 1.6% decline over the last 7 days and an 8.4% decline over the last 30 days, set against a 2.2% year to date return, 31.2% return over 1 year, 72.5% over 3 years and 80.8% over 5 years. Recent coverage has focused on Cisco Systems' role as a major networking and...

Paramount Skydance has reached a landmark agreement to acquire Warner Bros. Discovery (NasdaqGS:WBD). The deal combines major film and TV studios, along with extensive content libraries and franchises, under a single owner. Management plans include merging HBO Max with Paramount+, cutting costs across overlapping operations, and building an AI focused content production model. The transaction follows a competitive bidding process in which Netflix exited and received a breakup fee. For you...

In February 2026, UWM Holdings reported fourth-quarter 2025 net income of US$19.41 million, reaffirmed a US$0.10 per-share dividend payable in April 2026, and issued first-quarter 2026 revenue guidance initially in the US$650 million–US$850 million range, later updated to US$800 million–US$900 million alongside full-year 2026 guidance of US$3.5 billion–US$4.5 billion. An interesting development is UWM’s emphasis on AI-driven efficiency, with tools like its Mia voice assistant expected to...

If you are wondering whether Molson Coors Beverage shares are pricing in too much pessimism or offering quiet value, this is a good moment to take a closer look. The stock recently closed at US$45.87, with returns of a 4.6% decline over 7 days, an 11.4% decline over 30 days, a 3.2% decline year to date, a 21.0% decline over 1 year, and a 2.5% decline over 3 years, compared with a 10.0% gain over 5 years, which may have changed how investors see its risk and potential. Recent coverage of...

UiPath, Inc. recently launched agentic AI automation solutions for healthcare revenue cycle management and financial crime compliance, while also securing AIUC-1 certification for secure AI agents. These product launches and certifications arrive just after UiPath’s fiscal Q4 2026 earnings release, drawing attention to how AI-driven automation may influence its long-term growth profile. We’ll now examine how UiPath’s healthcare-focused agentic AI launch could influence the company’s broader...

Figma stock snapshot after recent trading moves Figma (FIG) has drawn fresh attention after a recent pullback, with the share price closing at US$28.35 and short term returns mixed across the past week, month, and past 3 months. See our latest analysis for Figma. The recent 7 day share price return of 7.77% and 1 day decline of 6.99% come after a strong 30 day share price return of 28.92%. However, the year to date share price return of 24.62% and 90 day share price return of 27.79% indicate...

If you are wondering whether FactSet Research Systems is attractively priced or still looks expensive, this article will walk through what the numbers are really saying about its current valuation. The share price closed at US$212.01, with returns of a 4.9% decline over 7 days, 2.3% over 30 days, a 25.6% decline year to date, a 50.1% decline over 1 year, a 46.5% decline over 3 years, and a 29.9% decline over 5 years, which may have changed how investors view its risk and return...

In recent quarters, Analog Devices reported quarterly revenue growth of 30% and guided for record Q2 revenue of about US$3.50 billion, driven by broad industrial strength and surging AI data center demand. An interesting element of this update is management’s view that the upswing reflects genuine end-market demand rather than temporary channel restocking, underscoring the depth of industrial and AI-related orders. Next, we’ll examine how this surge in genuine AI data center demand may...

If you are wondering whether Sysco is priced fairly today or if there is still value left on the table, this article walks you through what the numbers are really saying about the stock. Sysco shares last closed at US$84.29, with returns of 16.1% year to date and 16.3% over the past year, despite a 4.2% decline over 7 days and a 2.6% decline over 30 days that may be shifting how some investors see the risk and reward balance. Recent coverage has focused on Sysco's position as a major...

Four Corners Property Trust (NYSE:FCPT) has acquired automotive service properties in Texas and Indiana. Each property is operated under a long term triple net lease with a national automotive service tenant. The transactions extend FCPT’s reach beyond casual dining into essential, car focused retail locations. For you as an investor, these new deals highlight how Four Corners Property Trust, known for its net lease portfolio centered on restaurants, is adding more automotive service assets...

Coherus Oncology (CHRS) just posted its FY 2025 numbers with Q4 revenue of US$12.7 million and a basic EPS loss of US$0.39, while trailing 12 month figures show revenue of US$42.2 million and a basic EPS loss of US$1.56. Over recent quarters, the company has seen revenue move from US$7.6 million in Q1 2025 to US$12.7 million in Q4 2025, with quarterly basic EPS losses in a tight band around US$0.38 to US$0.41. This keeps the focus squarely on how efficiently each extra dollar of sales is...

In February 2026, Innoviva, Inc. reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, alongside full-year revenue of US$411.33 million and net income of US$271.17 million, all higher than the prior year. An interesting feature of this release is the sharp increase in basic earnings per share from continuing operations, with quarterly EPS rising to US$2.19 and full-year EPS reaching US$4.02 compared with the previous year. We’ll now explore how...

If you are wondering whether Expand Energy at US$104.67 is still worth your attention or if most of the upside has already been priced in, this article breaks down what the current share price might be implying about value. The stock has recently seen a 3.1% decline over 7 days and is down 5.2% over 30 days, even though the 1-year return sits at 7.6% and the 5-year return is a very large gain of around 2x. Recent coverage around Expand Energy has focused on its position within the energy...

BioMarin Pharmaceutical Inc. recently received FDA approval for a supplemental Biologics License Application expanding PALYNZIQ (pegvaliase-pqpz) use to pediatric phenylketonuria patients aged 12 and older, based on PEGASUS Phase 3 safety and efficacy data. This approval broadens PALYNZIQ’s eligible patient population but comes with a REMS restriction due to immune-mediated risks including anaphylaxis, highlighting both opportunity and safety management demands for BioMarin. We’ll now...

In early March 2026, Eaton announced a partnership with SPAN, investing US$75,000,000 to co-develop smart electrical panels that support affordable home electrification and reduce grid infrastructure needs, with joint solutions targeted for release in the second quarter of 2026. This move extends Eaton’s “Home as a Grid” approach by pairing its distribution and protection hardware with SPAN’s energy intelligence software, potentially deepening Eaton’s role in managing household energy use...

Burford Capital (NYSE:BUR) has been in focus after its Q4 2025 earnings showed lower revenue, a quarterly net loss, and reduced earnings per share, alongside insider share purchases and a new repurchase program. See our latest analysis for Burford Capital. At a share price of US$8.28, Burford Capital has had a softer run recently, with a 30 day share price return of 7.17% and a year to date share price return of 5.37%. The 1 year total shareholder return of a 36.94% decline contrasts with...

What the recent aerospace deals tell you about Curtiss-Wright Curtiss-Wright (CW) has been in focus after two recent aerospace and defense wins: a new partnership with Averna to build custom aerospace test systems and a four year U.S. Department of Defense contract for helicopter support equipment. See our latest analysis for Curtiss-Wright. The recent Averna partnership and U.S. Department of Defense contract arrive as Curtiss-Wright’s share price trades at US$703.61, with a 30-day share...

Arcus Biosciences recently reported full-year 2025 results, with revenue of US$247 million versus US$258 million in 2024 and a net loss of US$353 million, while also granting new employee equity awards under its 2020 Inducement Plan. More importantly for the story, Arcus outlined encouraging new clinical data and expansion plans for its HIF-2α inhibitor casdatifan in kidney cancer, alongside moves into inflammatory and autoimmune diseases that could reshape how investors view its pipeline...